Home  »  Industry   »  Zimmer Biomet Holdings Inc. (ZBH) Review – M...

Zimmer Biomet Holdings Inc. (ZBH) Review – Making Smarter Decisions

Zimmer Biomet Holdings Inc. (NYSE: ZBH) is -10.58% lower on its value in year-to-date trading and has touched a low of $100.39 and a high of $149.17 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ZBH stock was last observed hovering at around $111.77 in the last trading session, with the day’s loss setting it -1.57% off its average median price target of $125.00 for the next 12 months. It is also 24.0% off the consensus price target high of $145.00 offered by 26 analysts, but current levels are 3.33% higher than the price target low of $114.00 for the same period.

Currently trading at $110.20, the stock is -0.57% and -0.45% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.11 million and changing -1.40% at the moment leaves the stock -5.88% off its SMA200. ZBH registered -20.43% loss for a year compared to 6-month loss of -8.53%.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The stock witnessed a -1.04% gain in the last 1 month and extending the period to 3 months gives it a 4.64%, and is -5.33% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.57% over the week and 2.59% over the month.

Zimmer Biomet Holdings Inc. (ZBH) has around 19500 employees, a market worth around $23.75B and $7.41B in sales. Current P/E ratio is 77.55 and Fwd P/E is 15.44. Profit margin for the company is 3.10%. Distance from 52-week low is 9.77% and -26.12% from its 52-week high. The company has generated returns on investments over the last 12 months (3.20%).

Zimmer Biomet Holdings Inc. (ZBH) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Zimmer Biomet Holdings Inc. (ZBH) is a “Hold”. 26 analysts offering their recommendations for the stock have an average rating of 2.70, where 16 rate it as a Hold and 1 think it is a “Overweight”. 6 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.

Zimmer Biomet Holdings Inc. is expected to release its quarterly report on 11/03/2022.The EPS is expected to grow by 395.20% this year

Zimmer Biomet Holdings Inc. (ZBH) Top Institutional Holders

The shares outstanding are 209.82M, and float is at 209.62M with Short Float at 1.18%.

Zimmer Biomet Holdings Inc. (ZBH) Insider Activity

A total of 6 insider transactions have happened at Zimmer Biomet Holdings Inc. (ZBH) in the last six months, with sales accounting for 3 and purchases happening 3 times. The most recent transaction is an insider sale by VAN ZUILEN WILFRED, the company’s Pres, Europe, M. East & Africa. SEC filings show that VAN ZUILEN WILFRED sold 531 shares of the company’s common stock on Jul 05 at a price of $105.22 per share for a total of $55870.0. Following the sale, the insider now owns 2240.0 shares.

Zimmer Biomet Holdings Inc. disclosed in a document filed with the SEC on Mar 17 that Phipps Chad F (Sr. VP/Gen Counsel/Secretary) sold a total of 35,149 shares of the company’s common stock. The trade occurred on Mar 17 and was made at $121.97 per share for $4.29 million. Following the transaction, the insider now directly holds 41539.0 shares of the ZBH stock.

Still, SEC filings show that on Dec 14, Yi Sang (President, Asia Pacific) disposed off 2,800 shares at an average price of $124.14 for $0.35 million. The insider now directly holds 5,837 shares of Zimmer Biomet Holdings Inc. (ZBH).

Zimmer Biomet Holdings Inc. (ZBH): Who are the competitors?

The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading -0.76% down over the past 12 months and Medtronic plc (MDT) that is -32.94% lower over the same period. Stryker Corporation (SYK) is -20.79% down on the 1-year trading charts.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.